Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00911053 · ClinicalTrials.gov registry record · NA
Melatonin for Circadian Sleep Disorders in the Blind
A NA study, sponsored by Oregon Health and Science University.
- Terminated
- Registry status
- NA
- Development phase
- 59
- Enrollment target
NCT00911053 is a NA study that was terminated before completion, run by Oregon Health and Science University. The registered enrollment target is 59 participants.
The verdict
NCT00911053, a NA study, was terminated before completion, sponsored by Oregon Health and Science University.
- TERMINATED
- Registry status
- NA
- Development phase
- 59 participants
- Enrollment target
Study Summary
This research project consists of a three part study with five embedded sub studies. The first study phase identifies "body rhythms" of sleepiness/wakefulness and of melatonin levels for each subject (including sub-study 1). The second study phase identifies the optimum dose and timing of melatonin for regulating each individual's 24-hour sleep/waking cycle (including sub-study 2). The third study phase introduces a new independent variable, light (including sub-studies 3 and 4). Sub-study 5 is an optional longitudinal study. Sub-study 1 looks at how keeping a regular sleep schedule affects the body's natural rhythm. Sub-study 2 looks at how individuals metabolize melatonin. Sub-study 3 tests how individuals' endogenous melatonin production responds to bright outdoor light and Sub-study 4 tests a previous finding that artificial bright light exposed daily behind the knee can regulate the body clock. Sub-study 5 is an optional longitudinal study, an extension of the first study stage, for subjects whose rhythms are not clearly free-running.
Interventions
- DRUG Melatonin
- BEHAVIORAL Regular Sleep Schedule
- BEHAVIORAL Light
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 59 participants |
| Start Date | 1997-06 |
| Est. Completion | 2012-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00911053
The ClinicalTrials.gov registry entry for NCT00911053 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 59 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Oregon Health and Science University, which has 546 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Melatonin is the first listed.
NCT00911053 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00911053 about?
NCT00911053 is a clinical study titled "Melatonin for Circadian Sleep Disorders in the Blind". This research project consists of a three part study with five embedded sub studies. The first study phase identifies "body rhythms" of sleepiness/wakefulness and of melatonin levels for each subject (including sub-study 1). The second study phase identifies the optimum dose and timing of melatonin ...
What is the current status of trial NCT00911053?
This trial is currently terminated. It is a NA study. The enrollment target is 59 participants. The study started on 1997-06. Estimated completion is 2012-06.
What interventions are being tested in trial NCT00911053?
The interventions under investigation include: Melatonin (DRUG), Regular Sleep Schedule (BEHAVIORAL), Light (BEHAVIORAL).
Who is sponsoring clinical trial NCT00911053?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.